Exodus Point Capital Management, LP Verastem, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.06 - $2.1 $50,649 - $100,344	-47,783 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.05 - $3.2 $97,955 - $152,905	47,783 New	47,783 $98,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $27,640 - $44,289	-10,882 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $79,413 - $149,865	-30,900 Reduced 73.96%	10,882 $44,000
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $41,990 - $62,322	22,100 Added 112.29%	41,782 $103,000

Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $22,634 - $47,236	19,682 New	19,682 $42,000
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $24,486 - $37,060	-22,060 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $90,651 - $225,288	-53,640 Reduced 70.86%	22,060 $38,000
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $75,579 - $202,745	59,984 Added 381.67%	75,700 $200,000
Q4 2019 Feb 14, 2020	BUY	$0.86 - $1.44 $13,515 - $22,631	15,716 New	15,716 $21,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $575M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.